Erin K. McCreary, PharmD; Utibe R. Essien, MD, MPH; Chung-Chou H. Chang, PhD; et al.
open access
has audio
JAMA Health Forum. 2023;4(9):e232774. doi:10.1001/jamahealthforum.2023.2774
This quality improvement study examines the use of a weighted lottery system to allocate a limited number of doses of tixagevimab with cilgavimab equitably to disadvantaged populations.
-
Podcast:
Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy
Anna D. Sinaiko, PhD; Vilsa E. Curto, PhD; Katherine Ianni, BA; et al.
open access
JAMA Health Forum. 2023;4(9):e232875. doi:10.1001/jamahealthforum.2023.2875
This case-control study compares health care use, cost, and delivery for patients before vs after their primary care physician enters a vertical relationship, including ownership, affiliation, and joint contracting, with a health system.
Megan F. Hyland, MS; Rebecca M. Sachs, PhD; Lara Robillard, MPA; et al.
open access
JAMA Health Forum. 2023;4(9):e232941. doi:10.1001/jamahealthforum.2023.2941
This cross-sectional study assesses the extent to which Medicare Part B spending growth was associated with changes in price vs quantity, and how these trends interact with entry of new drugs into the marketplace.
Sean R. Dickson, JD, MPH; Katelyn E. James, BA
open access
JAMA Health Forum. 2023;4(9):e232951. doi:10.1001/jamahealthforum.2023.2951
This cross-sectional study evaluates whether research and nonresearch payments from drug manufacturers play a role in opthalmologists’ selection of therapies for age-related macular degeneration.
Hannah O. James, MS; Amal N. Trivedi, MD, MPH; David J. Meyers, PhD, MPH
open access
JAMA Health Forum. 2023;4(9):e233080. doi:10.1001/jamahealthforum.2023.3080
This cross-sectional study assesses enrollment and disenrollment patterns for Medicare Advantage plans from 2013 to 2018 among beneficiaries with complex health conditions, including Alzheimer disease and related dementias.
Bruce E. Landon, MD, MBA, MSc; Miranda B. Lam, MD, MBA; Mary Beth Landrum, PhD; et al.
open access
JAMA Health Forum. 2023;4(9):e233124. doi:10.1001/jamahealthforum.2023.3124
This cohort study examines opportunities for accountable care organizations and other risk-bearing organizations to achieve savings by steering patients to efficient medical oncology practices operating in specific geographic areas.
Maggie R. Salinger, MD, MPP, MPH; Brian Feltz, MBA; Stephanie H. Chan, MPH; et al.
open access
JAMA Health Forum. 2023;4(9):e233180. doi:10.1001/jamahealthforum.2023.3180
This cross-sectional study examines the association of impairment and disability identity with perceptions of procedural justice among adults with disabilities living in the US.
Ashley Lewis, BS; Renata E. Howland, PhD; Leora I. Horwitz, MD; et al.
open access
JAMA Health Forum. 2023;4(9):e233197. doi:10.1001/jamahealthforum.2023.3197
This cohort study investigates the association of New York state’s Medicaid value-based payment reform with utilization patterns in patients with mental illness.
Robert J. Dambrino IV, MD, MPH; Henry J. Domenico, MS; John A. Graves, PhD; et al.
open access
JAMA Health Forum. 2023;4(9):e233244. doi:10.1001/jamahealthforum.2023.3244
This cohort study quantifies and evaluates themes present in unsolicited patient complaints at a single institution before and after implementation of the 21st Century Cures Act information-blocking rule in 2021.
Roy H. Perlis, MD, MSc; Kristin Lunz Trujillo, PhD; Jon Green, PhD; et al.
open access
JAMA Health Forum. 2023;4(9):e233257. doi:10.1001/jamahealthforum.2023.3257
This survey study examines the association between non–evidence-based treatment for COVID-19 and endorsement of misinformation and trust in institutions among US residents with prior COVID-19 infection.